Silicone breast implants have been a controversial issue for some time and there is a strong connection between silicone breast implants and connective tissue disease.
In the case of medical conditions such as connective tissue disease occurring, the manufacturer may find themselves the subject of a claim.
Silicone is linked to chemically-related organic silicone compounds from silica (Si02), small quantities of which are found in artificial heart valves and baby bottle nipples.
Breast implants, first devised in 1962, are mainly used for cosmetic surgery (80 %) and reconstruction after surgery for breast cancer. By 1992, as many as 2.5 million women had received implants in North America and 100-150,000 British women are currently estimated to have them.
Manufacturing defects leading to leaks which put the health of women at risk have been in the news for some time.
The first reports of connective tissue disease after silicone injections appeared in 1982.
Breast implants are regulated as devices under the Therapeutic Goods Act (1989) and silicone gel-filled breast implants have been classed as high-risk products and have featured in product liability cases since 1992.
Evidence shows that breast implants can often be "bioreactive, immunogenic, toxic and inflammatory in the human body". As a foreign product, they can cause reactions in the human body and if the silicone leaks, this can cause diseases. Silicone can also generate antibodies that attack collagen, a component of connective tissue.
Some manufacturers have failed to take responsibility for their faulty products and have been accused of giving faulty information. They sometimes tell women that implants will last a lifetime and that ruptures occur less than one % of the time.
But published studies reveal a rupture rate of five to 51 % and many cases reveal a strong difference of opinion between manufacturer and consumer about published factual information.
A study of plastic and reconstructive surgery in 1993 linked rupture with the age of the implant. For implants between one and nine years old, for example, 35.7 % had ruptured. For those between 10 to 17 years old, 95.7 % had ruptured. Despite this fact, some manufacturers continue to attest that rupturing rates are not as high as reported.
While cosmetic surgery is well marketed, the medical side-effects often go unreported. The consequences can be extremely serious and put the health of women with breast implants at risk.
There is something that women with breasts implants who have suffered a serious injury can do about it, however. Manufacturers whose products are faulty (by leaking, for example) are responsible to their customers. If they fail to provide adequate information and products are defective, you may be able to make a claim.
Our panel of experts deal with personal injury cases all the time and have specific knowledge of breast implant cases. With an excellent success rate, there is a fantastic chance that your case could have a positive outcome. What's more, our panel solicitors all operate on a no win, no fee basis. This means that in the unlikely event that your claim is not successful, you are financially protected from costs.
To find out whether you too could make a claim with YouClaim, pick up the phone and dial 0800 10 757 95 today.